Literature DB >> 11111138

Cardiac involvement in primary myopathies.

J Finsterer1, C Stöllberger.   

Abstract

Simultaneous or temporarily staggered affection of both the skeletal as well as the cardiac muscle (cardiac involvement, CI) is a frequent finding in primary myopathies (MPs). CI leads to impulse generation defects, impulse conduction defects, thickened myocardium, left ventriculalr hypertrabeculation, dilatation of the cardiac cavities, secondary valve insufficiency, reduction of coronary vasodilative reserve, intracardial thrombus formation, and heart failure with systolic and diastolic dysfunction. CI has been found in Duchenne muscular dystrophy (MD), Becker MD, Emery-Dreifuss MD, facioscapulohumeral MD, sarcoglycanopathies, myotubular congenital MD, myotonic dystrophies type 1 and 2, proximal myotonic myopathy, myoadenylate deaminase deficiency, glycogenosis type II, III, IV, VII and IX, carnitine deficiency, mitochondriopathy, desmin MP, nemaline MP, central core disease, multicore MP, congenital fiber-type disproportion MP, Barth syndrome, McLeod syndrome and Bethlem MP. Patients with any of the above-mentioned myopathies should be cardiologically investigated as soon as their diagnosis is established, since sufficient cardiac therapy improves CI in MPs and since management of these patients is influenced by the degree of CI. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 11111138     DOI: 10.1159/000007039

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  20 in total

1.  The heart in muscular dystrophies.

Authors:  J Finsterer; Claudia Stöllberger
Journal:  Z Kardiol       Date:  2005-11

2.  Echocardiographic diagnosis, management and monitoring of pulmonary embolism with right heart thrombus in a patient with myotonic dystrophy: a case report.

Authors:  Bernd Hewing; Leyli Ghaeni; Henryk Dreger; Eva M Fallenberg; Alexander Panda; Gert Baumann; Adrian C Borges
Journal:  Cardiovasc Ultrasound       Date:  2010-05-16       Impact factor: 2.062

3.  Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy.

Authors:  Josef Finsterer; Finsterer Josef; Claudia Stöllberger; Stöllberger Claudia; Ellen Gelpi; Gelpi Ellen
Journal:  Int J Cardiovasc Imaging       Date:  2006-02-25       Impact factor: 2.357

4.  Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance.

Authors:  C Gaul; M Deschauer; C Tempelmann; S Vielhaber; H U Klein; H J Heinze; S Zierz; F Grothues
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

5.  [Facioscapulohumeral muscle dystrophy and heart disease].

Authors:  P Emmrich; V Ogunlade; T Gradistanac; S Daneschnejad; M C Koch; R Schober
Journal:  Z Kardiol       Date:  2005-05

6.  Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies.

Authors:  Izhar N Bagwan; Lucy V B Hooper; Mary N Sheppard
Journal:  Virchows Arch       Date:  2011-02-05       Impact factor: 4.064

7.  Early detection of cardiac involvement in Miyoshi myopathy: 2D strain echocardiography and late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  E Ryoung Choi; Sung-Ji Park; Yeon Hyeon Choe; Dong Ryeol Ryu; Sung-A Chang; Jin-Oh Choi; Sang-Chol Lee; Seung Woo Park; Byoung Joon Kim; Duk-Kyung Kim; Jae K Oh
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-24       Impact factor: 5.364

8.  Subcellular Ca2+ signaling in the heart: the role of ryanodine receptor sensitivity.

Authors:  Benjamin L Prosser; Christopher W Ward; W J Lederer
Journal:  J Gen Physiol       Date:  2010-08       Impact factor: 4.086

9.  Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.

Authors:  Yongping Yue; Ibrahim M Binalsheikh; Stacey B Leach; Timothy L Domeier; Dongsheng Duan
Journal:  Expert Opin Orphan Drugs       Date:  2015-12-17       Impact factor: 0.694

10.  [Familial predisposition and microbial etiology in dilated cardiomyopathy].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.